GHP employee appointed professor as part of collaboration between Karolinska Institutet and GHP

Eva Kosek, who works at GHP Stockholm Spine Center, has been appointed professor
in clinical pain research at Karolinska Institutet. Eva will also continue to
work with patients with pain issues at the clinic and to conduct a large part of
her research at GHP Stockholm Spine Center.
Eva Kosek is a specialist in both rehabilitation medicine and pain relief. She
has previously had combined duties, as she does clinical work at the GHP
Stockholm Spine Center and runs several research projects, both at GHP Stockholm
Spine Center and Karolinska Institutet (KI). The research concerns above all
mechanisms in long-term pain in the musculoskeletal system, how pain is
regulated and how genetic factors affect this regulation. Furthermore, several
factors are studied which are of significance for the outcome of surgical
treatment and training programmes.

Eva has now been appointed professor in clinical pain research at KI. This
professorship is partly financed by GHP in collaboration with KI. Eva will also
continue to run research projects and treat patients together with her
colleagues at GHP Stockholm Spine Center. One of the goals of the research is to
create a better understanding of different types of pain issues and thereby
become even better at treating above all long-term pain issues.

“Combined duties are a great solution for me. Running research projects at GHP
Stockholm Spine Center is incredibly effective thanks to interested and
supportive colleagues, short decision paths and a business at the leading edge
of spine issues,” says Eva Kosek, Professor at KI and senior consultant at GHP
Stockholm Spine Center.

For GHP this is an opportunity to develop the kind of collaboration that is the
future of health care in Stockholm. “We are very pleased about Eva’s appointment
and our part in this research. Now that an increasingly large part of health
care in Stockholm County Council is carried out outside public hospitals, we
private care providers must take our responsibility for the functioning of
research and education. Furthermore, Eva is conducting very exciting research,
which hopefully will be of great benefit to patients with these kinds of pain
issues,” says Daniel Öhman, CEO of GHP.

20 August 2015
Gothenburg, Sweden
GHP Specialty Care AB (publ)
Queries should be addressed to:
Daniel Öhman, CEO, Tel: +46 708 55 37 07
Tobias Linebäck, CFO and Head of Investor Relations, Tel: +46 708 55 37 19
GHP is an internationally active health care provider that operates specialist
clinics in a select number of diagnostic areas through the application of a
business model that is unique in the health care industry, where leading doctors
become partners and shareholders. Each clinic specialises in a particular
patient group, and this leads to increased efficiency and higher quality. This
is the cornerstone of GHP’s business philosophy – “Quality through
specialisation”. GHP shares are traded on the Small Cap list of Nasdaq Stockholm
under the ticker symbol “GHP”.

GHP Specialty Care AB (publ) | Corp. ID No. 556757-1103
Södra Hamngatan 45 | SE-411 06 Gothenburg | Sweden
Tel +46-31 712 53 00 | Fax +46-31 313 13 21 | www.ghp.se

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.